디지털 PCR 시장 규모, 점유율, 성장 분석 : 오퍼링별, 최종사용자별, 용도별, 지역별 - 산업 예측(2024-2031년)

Global Digital PCR Market size was valued at USD 6.83 Billion in 2022 and is poised to grow from USD 8.5 Billion in 2023 to USD 15.86 Billion by 2031, at a CAGR of 9.02 % during the forecast period (2024-2031).

The Global Digital PCR (Polymerase Chain Reaction) Market is experiencing rapid growth, driven by the rising need for precise and sensitive nucleic acid quantification and analysis. Digital PCR is highly valued for its accuracy and sensitivity, making it crucial for genetic testing, disease diagnosis, and research. The market aims to deliver advanced molecular diagnostic tools that provide healthcare professionals, clinical laboratories, and researchers with accurate and reliable results, ultimately enhancing patient care and scientific progress. Several factors propel the market's expansion, including the increasing incidence of genetic disorders and infectious diseases, the growing demand for personalized medicine, and advancements in genomic research. However, the market also contends with challenges such as the high cost of digital PCR equipment and limited awareness among potential users. Key market trends include the integration of digital PCR with next-generation sequencing technologies and the development of multiplex digital PCR assays that allow for the simultaneous detection of multiple targets. Despite these challenges, the market offers substantial growth opportunities. This is driven by the rising adoption of digital PCR in emerging economies, its expanding role in oncology and infectious disease diagnostics, and the ongoing introduction of innovative products with enhanced capabilities.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Digital PCR market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Digital PCR Market Segmental Analysis

Global Digital PCR Market is segmented based on offering, end user, application, and region. Based on offering, the market is segmented into qPCR Offering [qPCR Products (qPCR Reagents and Consumables, qPCR Instruments), qPCR Software, dPCR Services], dPCR Offerings [dPCR Reagents and Consumables, dPCR Instruments (Droplet digital PCR, Chip-based digital PCR, Beaming digital PCR), dPCR Software, dPCR Services]. Based on end user, the market is segmented into qPCR End Users and dPCR End Users [Hospitals and Diagnostic Laboratories, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, CROs and CDMOs, Forensic Laboratories, Other End Users]. Based on application, the market is segmented into Clinical Applications [Infectious Disease Testing, Oncology Testing, Blood Screening, Transplant Diagnostics, Other Clinical Applications], Research Applications [Single-cell analysis, Stem cell research, Gene expression, Others], Forensic Applications, Environmental Applications, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Digital PCR Market

Technological advancements in digital polymerase chain reaction (dPCR) are set to greatly impact market growth. These innovations represent a notable shift from traditional PCR methods, providing direct nucleic acid quantification and clonal amplification. The rising demand for state-of-the-art dPCR devices, alongside heightened research and development efforts, has led to the emergence of advanced PCR technologies that deliver significant advantages. This progress underscores the transformative potential of dPCR in improving molecular diagnostics and research outcomes.

Restraints in the Global Digital PCR Market

The uptake of digital PCR technology may be constrained by the significant initial costs involved in acquiring the necessary instruments and reagents. Digital PCR systems demand specialized equipment and consumables, which can be costly for research labs and smaller healthcare facilities. These high expenses might restrict access to digital PCR technology, particularly in resource-limited environments or for researchers operating with tight budgets.

Market Trends of the Global Digital PCR Market

Digital PCR and next-generation sequencing (NGS) technologies are complementary and can be integrated for a more comprehensive genomic analysis. By combining digital PCR's precise quantification capabilities with NGS's sequencing data, researchers gain access to both qualitative and quantitative insights. This integration enhances the identification of rare genetic variants, validates NGS findings, and allows for the detailed analysis of complex genomic changes associated with diseases.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors of The Market
• Degree Of Competition
• Top Investment Pockets
• Market Attractive Index
• Ecosystem Mapping
• Pricing Analysis
• Patent Analysis
• Trade Analysis
• Technology Analysis
• Supply Chain Analysis
• Value Chain Analysis

Global Digital PCR Market by Offering

• QPCR Offering
  • QPCR Products
    • QPCR Reagents and Consumables
    • QPCR Instruments
  • QPCR Software
  • QPCR Services
• DPCR Offering
  • DPCR Reagents and Consumables
  • DPCR Instruments
    • Droplet digital PCR
    • Chip-based digital PCR
    • Beaming digital PCR
  • DPCR Software
  • DPCR Services

Global Digital PCR Market by Application

• QPCR & DPCR Application
  • Clinical Applications
  • Infectious Disease Testing
  • Oncology Testing
  • Blood Screening
  • Transplant Diagnostics
  • Others
  • Research Applications
  • Single-cell analysis
  • Stem cell research
  • Gene expression
  • Others
  • Forensic Applications
  • Environmental Applications
  • Others

Global Digital PCR Market by End-User

• QPCR & DPCR End-User
  • Hospitals and Diagnostic Laboratories
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • CROs and CDMOs
  • Forensic Laboratories
  • Others

Global Digital PCR Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JN Medsys (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Formulatrix, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stilla Technologies (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quantabio (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eppendorf AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LGC Biosearch Technologies (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments